Investors.modernatx.com

Moderna and OpenAI Collaborate To Advance mRNA Medicine

WEBCAMBRIDGE, MA AND SAN FRANCISCO, CA / ACCESSWIRE / April 24, 2024 / Moderna, Inc. (NASDAQ:MRNA) and OpenAI today announced their ongoing …

Actived: 3 days ago

URL: https://investors.modernatx.com/news/news-details/2024/Moderna-and-OpenAI-Collaborate-To-Advance-mRNA-Medicine/default.aspx

Moderna Announces Clinical and Program Updates at 3rd Annual …

WEBModerna is advancing its global public health strategy with three new initiatives aimed at advancing mRNA vaccines. First, Moderna has announced a …

Category: Health Go Health

Moderna Advances Multiple Vaccine Programs to Late-Stage …

WEBModerna is also working with health authorities to align the timing of COVID-19 and flu vaccine launches to help improve public health. For RSV, Moderna estimates …

Category: Health Go Health

Moderna Reports Second Quarter Fiscal Year 2021 Financial …

WEBSecond Quarter 2021 Financial Results. Revenue: Total revenue was $4.4 billion for the three months ended June 30, 2021, compared to $67 million for the same …

Category: Health Go Health

Moderna Expands the Field of mRNA Medicine with Positive …

WEBCompany's flu vaccine, mRNA-1010, met its primary endpoint in Phase 3 trial; separate Phase 1/2 data demonstrated higher HAI titers than Fluzone HD Vaccine …

Category: Health Go Health

Moderna Announces Positive Phase 1/2 Data from mRNA-1083, …

WEBmRNA-1083 showed strong immunogenicity against influenza and COVID-19, with an acceptable reactogenicity and safety profile, compared to licensed standalone …

Category: Health Go Health

Moderna Receives Health Canada Authorization for Second …

WEBmRNA-1273.222 is the second Moderna bivalent COVID-19 vaccine approved by Health Canada, following the approval of mRNA-1273.214 (SPIKEVAX …

Category: Health Go Health

CEPI and Moderna Harness mRNA Technology to Advance 100 …

WEBCEPI and Moderna. CEPI and Moderna first worked together in early 2020, when CEPI provided early catalytic investment of $0.9 million to support the production …

Category: Health Go Health

IAVI and Moderna Partner to Tackle Broad Global Health Priorities …

WEBIAVI is a nonprofit scientific research organization dedicated to addressing urgent, unmet global health challenges including HIV, tuberculosis, and emerging …

Category: Health Go Health

Moderna Announces First Participants Dosed in Phase 3 Study of …

WEBmRNA-1010 is Moderna's first seasonal influenza vaccine candidate to enter a Phase 3 trial mRNA-1010 is one of several influenza vaccine candidates being …

Category: Health Go Health

Moderna to Host Fifth Annual Investor Event For Vaccines and …

WEBBy working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and. …

Category: Medicine Go Health

Moderna to Provide Business and Pipeline Updates at the 2023 J.P

WEBCAMBRIDGE, MA / ACCESSWIRE / January 3, 2023 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) …

Category: Health Go Health

Moderna Announces Additional Investments to Increase Global …

WEBThe Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) …

Category: Medical Go Health

Impacting Human Health: Reflecting on our ESG Progress

WEBEarlier this year, we evolved our mission to better reflect our belief that Moderna’s mRNA medicines will continue to have a profound impact on human health. …

Category: Medicine Go Health

Moderna’s Commitment to Patient Access in the United States

WEBModerna’s vaccines have protected the lives of hundreds of millions of people around the world from COVID-19 and have dramatically lessened the burden of …

Category: Health Go Health

Moderna Provides Business and Pipeline Updates at 42nd Annual …

WEBJamey Mock, Chief Financial Officer of Moderna, will present an update on the Company and its pipeline of mRNA development programs on Monday, January 8 …

Category: Health Go Health

Moderna Shares Environmental, Social and Governance Highlights …

WEBModerna continues development of at least 15 vaccine programs targeting emerging or neglected infectious diseases by 2025 as part of global health program …

Category: Health Go Health

Moderna Announces Contract with Brazil to Supply 12.5 million …

WEBThis contract follows the Brazilian Health Regulatory Agency's (ANVISA) approval of Moderna's COVID-19 vaccine in March 2024, which encodes the spike …

Category: Health Go Health

Moderna Reviews its Environmental, Social and Governance (ESG) …

WEBThe Company's ESG strategy demonstrates its efforts to advance global health and environmental sustainability, as well as its commitments to employees and …

Category: Health Go Health

Initiation of the tender procedure for mRNA COVID-19 vaccines by …

WEBA diversified supply of mRNA COVID-19 vaccines is vital for Europe and public health worldwide. mRNA technology has shown itself to be a proven platform for …

Category: Health Go Health